4//SEC Filing
Avnur Zafrira 4
Accession 0001209191-18-021336
CIK 0001035354other
Filed
Mar 21, 8:00 PM ET
Accepted
Mar 22, 7:18 PM ET
Size
5.4 KB
Accession
0001209191-18-021336
Insider Transaction Report
Form 4
Avnur Zafrira
Director
Transactions
- Purchase
Common Stock
2018-03-21$7.60/sh+263$1,999→ 263 total(indirect: By Spouse)
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.59 to $7.60, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4.
Documents
Issuer
Eloxx Pharmaceuticals, Inc.
CIK 0001035354
Entity typeother
Related Parties
1- filerCIK 0001726049
Filing Metadata
- Form type
- 4
- Filed
- Mar 21, 8:00 PM ET
- Accepted
- Mar 22, 7:18 PM ET
- Size
- 5.4 KB